Suchergebnisse - "Ghosh, Nilanjan"

PubPharm (183)

1

Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis : Unravelling Underlying Molecular Mechanisms

enthalten in: Planta medica | 2024

von Banerjee, T. | Sarkar, A. | Ali, S. | +4

2

Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma : Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Wang, M. | Siddiqi, T. | Gordon, L. | +17

3

Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma : patient-reported outcomes from the PILOT study

enthalten in: Haematologica | 2024

von Gordon, L. | Liu, F. | Braverman, J. | +8

4

Wide Composite Resection of Sternal Metastasis & Reconstruction Using Titanium Mesh Implant and Myocutaneous Flap in Differentiated Thyroid Carcinoma : Case Report of Two Cases

enthalten in: Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India | 2024

von Rojesara, M. | Sattavan, S. | Sharma, M. | +8

5

Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001

enthalten in: Blood | 2024

von Abramson, J. | Palomba, M. | Gordon, L. | +14

CommentIn: Blood. 2024 Feb 1;143(5):379-380. - PMID 38300610

6

Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma : a phase 1b/2 trial

enthalten in: Nature medicine | 2024

von Budde, L. | Olszewski, A. | Assouline, S. | +21

7

Finding structural requirements of structurally diverse α-glucosidase and α-amylase inhibitors through validated and predictive 2D-QSAR and 3D-QSAR analyses

enthalten in: Journal of molecular graphics & modelling | 2024

von Mitra, S. | Chatterjee, S. | Bose, S. | +6

8

Genetic Predictors of Ibrutinib-related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Hamadeh, I. | Patel, J. | Jacobs, R. | +11

9

Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing

enthalten in: ResearchSquare.com | 2023

von Robinson, M. | Morris, S. | Jandrisevits, E. | +9

10

Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing

enthalten in: The pharmacogenomics journal | 2023

von Patel, J. | Robinson, M. | Morris, S. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]